Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
3.910
-0.190 (-4.63%)
Sep 17, 2025, 4:00 PM EDT - Market closed

Lantern Pharma Statistics

Total Valuation

Lantern Pharma has a market cap or net worth of $42.23 million. The enterprise value is $26.47 million.

Market Cap42.23M
Enterprise Value 26.47M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date Nov 6, 2025
Ex-Dividend Date n/a

Share Statistics

Lantern Pharma has 10.80 million shares outstanding. The number of shares has decreased by -0.09% in one year.

Current Share Class 10.80M
Shares Outstanding 10.80M
Shares Change (YoY) -0.09%
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.42%
Owned by Institutions (%) 10.90%
Float 8.20M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.37
P/TBV Ratio 3.37
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.01.

Current Ratio 3.52
Quick Ratio 3.26
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -88.59% and return on invested capital (ROIC) is -58.49%.

Return on Equity (ROE) -88.59%
Return on Assets (ROA) -48.35%
Return on Invested Capital (ROIC) -58.49%
Return on Capital Employed (ROCE) -163.55%
Revenue Per Employee n/a
Profits Per Employee -$802,029
Employee Count24
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +3.99% in the last 52 weeks. The beta is 1.47, so Lantern Pharma's price volatility has been higher than the market average.

Beta (5Y) 1.47
52-Week Price Change +3.99%
50-Day Moving Average 4.25
200-Day Moving Average 3.83
Relative Strength Index (RSI) 43.80
Average Volume (20 Days) 112,877

Short Selling Information

The latest short interest is 459,566, so 4.26% of the outstanding shares have been sold short.

Short Interest 459,566
Short Previous Month 523,402
Short % of Shares Out 4.26%
Short % of Float 5.60%
Short Ratio (days to cover) 3.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -20.50M
Pretax Income -17.75M
Net Income -19.25M
EBITDA -20.48M
EBIT -20.50M
Earnings Per Share (EPS) -$1.79
Full Income Statement

Balance Sheet

The company has $15.90 million in cash and $145,039 in debt, giving a net cash position of $15.76 million or $1.46 per share.

Cash & Cash Equivalents 15.90M
Total Debt 145,039
Net Cash 15.76M
Net Cash Per Share $1.46
Equity (Book Value) 12.52M
Book Value Per Share 1.16
Working Capital 12.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.87 million and capital expenditures -$7,270, giving a free cash flow of -$17.87 million.

Operating Cash Flow -17.87M
Capital Expenditures -7,270
Free Cash Flow -17.87M
FCF Per Share -$1.66
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Lantern Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.09%
Shareholder Yield 0.09%
Earnings Yield -45.59%
FCF Yield -42.33%

Analyst Forecast

The average price target for Lantern Pharma is $25.00, which is 539.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target $25.00
Price Target Difference 539.39%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) 3.70%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1